Why the study?
The authors sought to overview data from the CURRENT AS registry to discuss three major clinical practice issues in severe AS: underuse of SAVR in symptomatic patients, management of asymptomatic patients, and management of low-gradient severe AS.
Does an initial AVR strategy improve clinical outcomes compared to a conservative strategy in patients with severe aortic stenosis?
Does an initial AVR strategy improve clinical outcomes compared to a conservative strategy in patients with severe aortic stenosis?
This review of the CURRENT AS registry highlights the underuse of SAVR in symptomatic severe AS and supports an initial AVR strategy for both asymptomatic and low-gradient severe AS patients.
No takes yet. Share an insight, caveat, or question.
Highlights under-referral for surgery in severe AS; leaves open optimal referral pathways in the TAVI era.
Taniguchi et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: